COCRYSTAL PHARMA INC (COCP:NASDAQ)
$1.03 -0.01 (-0.9615%)
Analysed COCRYSTAL PHARMA INC (COCP:NASDAQ) News Sources
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
31-03-2026
yahoo.com
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
15-05-2026
yahoo.com
COCP: Presentation Highlights CDI-988
01-06-2026
yahoo.com
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
03-06-2026
yahoo.com
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
03-08-2026
yahoo.com
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
17-08-2026
yahoo.com
COCP: $5 Million Private Placement with OPKO Health
20-08-2026
yahoo.com
Cocrystal Pharma: The Strategic Reset Investors May Be Missing
31-08-2026
yahoo.com
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
09-09-2026
yahoo.com
Cocrystal Pharma’s new CEO hopes to crack the norovirus code
15-09-2026
pharmavoice.com
What is the current price of COCRYSTAL PHARMA INC (COCP:NASDAQ)?
The current price of COCRYSTAL PHARMA INC (COCP:NASDAQ) is $1.03.
COCRYSTAL PHARMA INC (COCP:NASDAQ) absolute price change since previous trading day?
The absolute price change of COCRYSTAL PHARMA INC (COCP:NASDAQ) since the previous trading day is $-0.01.
COCRYSTAL PHARMA INC (COCP:NASDAQ) percentage price change since previous trading day?
The percentage price change of COCRYSTAL PHARMA INC (COCP:NASDAQ) since the previous trading day is -0.9615%.
What is the most recent average sentiment score for COCRYSTAL PHARMA INC (COCP:NASDAQ)?
The most recent average sentiment score for COCRYSTAL PHARMA INC (COCP:NASDAQ) is 55 out of 100.
What is the most recent average sentiment for COCRYSTAL PHARMA INC (COCP:NASDAQ)?
The most recent sentiment for COCRYSTAL PHARMA INC (COCP:NASDAQ) is .
SEC-8K** Filing Available For COCRYSTAL PHARMA INC (COCP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.